These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 19945431

  • 21. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

  • 22. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S, Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY.
    Mol Pharmacol; 2007 Nov 01; 72(5):1269-79. PubMed ID: 17684158
    [Abstract] [Full Text] [Related]

  • 23. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP, Zisman A, Bonavida B.
    Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140
    [Abstract] [Full Text] [Related]

  • 24. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K, Douglas L, Delaney A, Houghton JA.
    Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455
    [Abstract] [Full Text] [Related]

  • 25. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
    Yano K, Horinaka M, Yoshida T, Yasuda T, Taniguchi H, Goda AE, Wakada M, Yoshikawa S, Nakamura T, Kawauchi A, Miki T, Sakai T.
    Int J Oncol; 2011 Feb 01; 38(2):365-74. PubMed ID: 21165560
    [Abstract] [Full Text] [Related]

  • 26. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
    Lee J, Hwangbo C, Lee JJ, Seo J, Lee JH.
    Oncol Rep; 2010 Jan 01; 23(1):229-37. PubMed ID: 19956887
    [Abstract] [Full Text] [Related]

  • 27. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 28. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
    Kang J, Bu J, Hao Y, Chen F.
    Prostate Cancer Prostatic Dis; 2005 Dec 07; 8(3):274-9. PubMed ID: 15897917
    [Abstract] [Full Text] [Related]

  • 29. RNAi silencing of the MEKK3 gene promotes TRAIL-induced apoptosis in MCF-7 cells and suppresses the transcriptional activity of NF-κB.
    Guo SY, Liu SG, Liu L, Zhou XJ, Gu Y.
    Oncol Rep; 2012 Feb 07; 27(2):441-6. PubMed ID: 22020406
    [Abstract] [Full Text] [Related]

  • 30. Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression.
    Wang W, Zhao J, Wang H, Sun Y, Peng Z, Zhou G, Fan L, Wang X, Yang S, Wang R, Fang D.
    Exp Cell Res; 2010 Sep 10; 316(15):2456-64. PubMed ID: 20595005
    [Abstract] [Full Text] [Related]

  • 31. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A.
    Gynecol Oncol; 2004 Jun 10; 93(3):594-604. PubMed ID: 15196850
    [Abstract] [Full Text] [Related]

  • 32. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
    Park JH, Lin ML, Nishidate T, Nakamura Y, Katagiri T.
    Cancer Res; 2006 Sep 15; 66(18):9186-95. PubMed ID: 16982762
    [Abstract] [Full Text] [Related]

  • 33. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.
    Liu Y, Liu H, Cao H, Song B, Zhang W, Zhang W.
    Oncol Rep; 2015 Dec 15; 34(6):3288-96. PubMed ID: 26503118
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells.
    Kato T, Inoue H, Imoto S, Tamada Y, Miyamoto T, Matsuo Y, Nakamura Y, Park JH.
    Oncotarget; 2016 Apr 05; 7(14):17652-64. PubMed ID: 26933922
    [Abstract] [Full Text] [Related]

  • 36. Characterization of a MAPKK-like protein kinase TOPK.
    Matsumoto S, Abe Y, Fujibuchi T, Takeuchi T, Kito K, Ueda N, Shigemoto K, Gyo K.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):997-1004. PubMed ID: 15541388
    [Abstract] [Full Text] [Related]

  • 37. Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase.
    Zhao R, Choi BY, Wei L, Fredimoses M, Yin F, Fu X, Chen H, Liu K, Kundu JK, Dong Z, Lee MH.
    Br J Pharmacol; 2020 May 17; 177(10):2303-2319. PubMed ID: 31985814
    [Abstract] [Full Text] [Related]

  • 38. PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells.
    Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D, Rapoport AP.
    Blood Cells Mol Dis; 2001 May 17; 27(5):825-9. PubMed ID: 11783945
    [Abstract] [Full Text] [Related]

  • 39. Caspase-8 mutations associated with head and neck cancer differentially retain functional properties related to TRAIL-induced apoptosis and cytokine induction.
    Cui Z, Dabas H, Leonard BC, Shiah JV, Grandis JR, Johnson DE.
    Cell Death Dis; 2021 Aug 06; 12(8):775. PubMed ID: 34362880
    [Abstract] [Full Text] [Related]

  • 40. T-LAK cell-originated protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 prevents UVB-induced apoptosis in RPMI7951 melanoma cells through the regulation of Prx1 peroxidase activity.
    Zykova TA, Zhu F, Vakorina TI, Zhang J, Higgins LA, Urusova DV, Bode AM, Dong Z.
    J Biol Chem; 2010 Sep 17; 285(38):29138-46. PubMed ID: 20647304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.